Authors:
Hocini, H
Becquart, P
Bouhlal, H
Adle-Biassette, H
Kazatchkine, MD
Belec, L
Citation: H. Hocini et al., Secretory leukocyte protease inhibitor inhibits infection of monocytes andlymphocytes with human immunodeficiency virus type 1 but does not interfere with transcytosis of cell-associated virus across tight epithelial barriers, CL DIAG LAB, 7(3), 2000, pp. 515-518
Authors:
Lacroix-Desmazes, S",Sooryanarayana,"Moreau, A
Horn, MP
Kazatchkine, MD
Kaveri, SV
Citation: A. Lacroix-desmazes, S",sooryanarayana,"moreau et al., Factor VIII inhibitor with catalytic activity towards factor VIII, CHEM IMMUNO, 77, 2000, pp. 102-114
Authors:
Stahl, D
Lacroix-Desmazes, S
Kaveri, SV
Kazatchkine, MD
Citation: D. Stahl et al., Polyreactivity of disease-associated anti-RBC IgG autoantibodies of patients with warm autoimmune haemolytic anaemia and natural anti-RBC IgG autoantibodies of healthy individuals, SC J IMMUN, 52(2), 2000, pp. 190-199
Authors:
Delibrias, CC
Fischer, EM
Kazatchkine, MD
Citation: Cc. Delibrias et al., The enhancing role of complement in human immunodeficiency virus infection: Soluble recombinant CR1 (CD35) inhibits complement-mediated enhancement of infection of a CD4-positive T-cell line with human immunodeficiency virus-1, SC J IMMUN, 51(5), 2000, pp. 526-529
Authors:
Bar-Dayan, Y
Bar-Dayan, Y
Bonnin, E
Bloch, MF
Schweitzer, R
Ravid, M
Kazatchkine, MD
Kaveri, SV
Citation: Y. Bar-dayan et al., Neutralization of disease associated autoantibodies by an immunoglobulin M- and immunoglobulin A-enriched human intravenous immunoglobulin preparation, SC J IMMUN, 51(4), 2000, pp. 408-414
Authors:
Piketty, C
Race, E
Castiel, P
Belec, L
Peytavin, G
Si-Mohamed, A
Gonzalez-Canali, G
Weiss, L
Clavel, F
Kazatchkine, MD
Citation: C. Piketty et al., Phenotypic resistance to protease inhibitors in patients who fail on highly active antitetroviral therapy predicts the outcome at 48 weeks of a five-drug combination including ritonavir, saquinavir and efavirenz, AIDS, 14(5), 2000, pp. 626-628
Authors:
Landau, A
Batisse, D
Piketty, C
Jian, R
Kazatchkine, MD
Citation: A. Landau et al., Lack of interference between ribavirin and nucleosidic analogues in HIV/HCV co-infected individuals undergoing concomitant antiretroviral and anti-HCV combination therapy, AIDS, 14(12), 2000, pp. 1857-1858
Authors:
Karmochkine, M
Mohamed, AS
Piketty, C
Ginsburg, C
Raguin, G
Schneider-Fauveau, V
Gutmann, L
Kazatchkine, MD
Belec, L
Citation: M. Karmochkine et al., The cumulative occurrence of resistance mutations in the HIV-1 protease gene is associated with failure of salvage therapy with ritonavir and saquinavir in protease inhibitor-experienced patients, ANTIVIR RES, 47(3), 2000, pp. 179-188
Authors:
Heard, I
Tassie, JM
Schmitz, V
Mandelbrot, L
Kazatchkine, MD
Orth, G
Citation: I. Heard et al., Increased risk of cervical disease among human immunodeficiency virus-infected women with severe immunosuppression and high human papillomavirus load, OBSTET GYN, 96(3), 2000, pp. 403-409
Authors:
Belec, L
Piketty, C
Si-Mohamed, A
Goujon, C
Hallouin, MC
Cotigny, S
Weiss, L
Kazatchkine, MD
Citation: L. Belec et al., High levels of drug-resistant human immunodeficiency virus variants in patients exhibiting increasing CD4+ T cell counts despite virologic failure ofprotease inhibitor-containing antiretroviral combination therapy, J INFEC DIS, 181(5), 2000, pp. 1808-1812
Authors:
Becquart, P
Hocini, H
Levy, M
Sepou, A
Kazatchkine, MD
Belec, L
Citation: P. Becquart et al., Secretory anti-human immunodeficiency virus (HIV) antibodies in colostrum and breast milk are not a major determinant of the protection of early postnatal transmission of HIV, J INFEC DIS, 181(2), 2000, pp. 532-539
Authors:
Rowe, JA
Rogerson, SJ
Raza, A
Moulds, JM
Kazatchkine, MD
Marsh, K
Newbold, CI
Atkinson, JP
Miller, LH
Citation: Ja. Rowe et al., Mapping of the region of complement receptor (CR) 1 required for Plasmodium falciparum resetting and demonstration of the importance of CR1 in resetting in field isolates, J IMMUNOL, 165(11), 2000, pp. 6341-6346
Authors:
Hocini, H
Iscaki, S
Bouvet, JP
Kazatchkine, MD
Belec, L
Citation: H. Hocini et al., An ELISA method to measure total and specific human secretory IgA subclasses based on selective degradation by IgA1-protease, J IMMUNOL M, 235(1-2), 2000, pp. 53-60
Authors:
Jubault, V
Penfornis, A
Schillo, F
Hoen, B
Izembart, M
Timsit, J
Kazatchkine, MD
Gilquin, J
Viard, JP
Citation: V. Jubault et al., Sequential occurrence of thyroid autoantibodies and Graves' disease after immune restoration in severely immunocompromised human immunodeficiency virus-1-infected patients, J CLIN END, 85(11), 2000, pp. 4254-4257
Authors:
Moreau, A
Lacroix-Desmazes, S
Stieltjes, N
Saenko, E
Kaveri, SV
D'Oiron, R
Sultan, Y
Scandella, D
Kazatchkine, MD
Citation: A. Moreau et al., Antibodies to the FVIII light chain that neutralize FVIII procoagulant activity are present in plasma of nonresponder patients with severe hemophiliaA and in normal polyclonal human IgG, BLOOD, 95(11), 2000, pp. 3435-3441
Authors:
Stahl, D
Lacroix-Desmazes, S
Heudes, D
Mouthon, L
Kaveri, SV
Kazatchkine, MD
Citation: D. Stahl et al., Altered control of self-reactive IgG by autologous IgM in patients with warm autoimmune hemolytic anemia, BLOOD, 95(1), 2000, pp. 328-335
Authors:
Grabar, S
Le Moing, V
Goujard, C
Leport, C
Kazatchkine, MD
Costagliola, D
Weiss, L
Citation: S. Grabar et al., Clinical outcome of patients with HIV-1 infection according to immunologicand virologic response after 6 months of highly active antiretroviral therapy, ANN INT MED, 133(6), 2000, pp. 401-410
Authors:
Lacroix-Desmazes, S
Moreau, A",Sooryanarayana,"Bonnemain, C
Stieltjes, N
Pashov, A
Sultan, Y
Hoebeke, J
Kazatchkine, MD
Kaveri, SV
Citation: S. Lacroix-desmazes et al., Catalytic activity of antibodies against factor VIII in patients with hemophilia A, NAT MED, 5(9), 1999, pp. 1044-1047
Authors:
Piketty, C
Castiel, P
Giral, P
Lhomme, JP
Boubilley, D
Olievenstein, C
Lert, F
Kazatchkine, MD
Citation: C. Piketty et al., Lack of legal income is strongly associated with an increased risk of AIDSand death in HIV-infected injecting drug users, AIDS CARE, 11(4), 1999, pp. 429-436